Anti-CRISPR Proteins Decrease Damaging Off-target Effects

News   Jul 13, 2017 | Original story from UC Berkeley

 
Anti-CRISPR Proteins Decrease Damaging Off-target Effects

Credit: UC Berkeley

 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Test Successfully Identifies Which Research Results in Mice Will Help Humans With MS

News

In determining which genes are conserved across species, the researchers also discovered a new gene that improves myelin repair.

READ MORE

Cambridge Epigenetix, NuGEN Technologies Sign Agreement to Combine Leading Technologies in Epigenetics Research

News

Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE